Copyright
©The Author(s) 2024.
World J Gastroenterol. Mar 28, 2024; 30(12): 1751-1763
Published online Mar 28, 2024. doi: 10.3748/wjg.v30.i12.1751
Published online Mar 28, 2024. doi: 10.3748/wjg.v30.i12.1751
Figure 6 Performance of early DNA-thioguanine and 6-thioguanine nucleotides concentrations in the prediction of late leucopenia in the entire population, nudix hydrolase 15/thiopurine methyltransferase wild-type and heterozygous subgroups.
A: Performance in the entire population; B: Performance in nudix hydrolase 15 (NUDT15)/thiopurine methyltransferase (TPMT) wild-type subgroups; C: Performance in NUDT15/TPMT heterozygous subgroups. 6TGN: 6-thioguanine nucleotides; DNATG: DNA-thioguanine; AUC: Area under the curve; FPR: False positive rate; TPR: True positive rate.
- Citation: Yang T, Chao K, Zhu X, Wang XD, Chan S, Guan YP, Mao J, Li P, Guan SX, Xie W, Gao X, Huang M. Early proactive monitoring of DNA-thioguanine in patients with Crohn’s disease predicts thiopurine-induced late leucopenia in NUDT15/TPMT normal metabolizers. World J Gastroenterol 2024; 30(12): 1751-1763
- URL: https://www.wjgnet.com/1007-9327/full/v30/i12/1751.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i12.1751